Boston Trust Walden’s Darling Ingredients DAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-483,881
Closed -$5.09M 343
2015
Q4
$5.09M Sell
483,881
-201,540
-29% -$2.1M 0.09% 215
2015
Q3
$7.7M Sell
685,421
-31,974
-4% -$409K 0.13% 206
2015
Q2
$10.5M Sell
717,395
-21,370
-3% -$315K 0.16% 185
2015
Q1
$10.3M Sell
738,765
-23,752
-3% -$391K 0.15% 178
2014
Q4
$13.8M Sell
762,517
-489,390
-39% -$8.85M 0.21% 164
2014
Q3
$22.9M Sell
1,251,907
-364,205
-23% -$7.04M 0.35% 127
2014
Q2
$33.8M Buy
1,616,112
+40,783
+3% +$823K 0.49% 92
2014
Q1
$31.5M Sell
1,575,329
-28,113
-2% -$564K 0.47% 99
2013
Q4
$33.5M Sell
1,603,442
-97,197
-6% -$2.08M 0.49% 91
2013
Q3
$36M Buy
1,700,639
+49,216
+3% +$1M 0.55% 78
2013
Q2
$30.8M Buy
+1,651,423
New +$30.5M 0.5% 90

Other funds holding DAR

Boston Trust Walden's DAR Position: Q1 2016 in Review

Boston Trust Walden sold out of Darling Ingredients (DAR) in Q1 2016, closing a stake of 483,881 shares — an estimated $5.09M sold.

Boston Trust Walden first reported a position in DAR in Q2 2013 and held it in 11 quarters. The position peaked at $36M in Q3 2013. 259 funds tracked by Wall St. Rank hold DAR as of Q1 2016.

  • Boston Trust Walden reported no remaining Darling Ingredients position as of Q1 2016 after selling out during the quarter.
  • Boston Trust Walden sold 483,881 Darling Ingredients shares in Q1 2016, an estimated $5.09M.
  • Boston Trust Walden first reported a position in Darling Ingredients in Q2 2013 and held it in 11 quarters.
  • Boston Trust Walden's Darling Ingredients position peaked at $36M in Q3 2013.
  • 259 funds tracked by Wall St. Rank held Darling Ingredients as of Q1 2016.

Based on Boston Trust Walden's 13F filing for Q1 2016, filed 19 Apr 2016.